about
Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-AnalysisEffects of fibrates in kidney disease: a systematic review and meta-analysisDevelopment and implementation of an online clinical pathway for adult chronic kidney disease in primary care: a mixed methods studyIntensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis.Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.Short-term change in eGFR and risk of cardiovascular events.Kidney function, albuminuria and life expectancy.Patients with chronic kidney disease and their intent to use electronic personal health recordsIncidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysisEffects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis.Assessing the extent to which current clinical research is consistent with patient priorities: a scoping review using a case study in patients on or nearing dialysis.A systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients.Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials.The See Kidney Disease Targeted Screening Program for CKD.Proteinuria and rate of change in kidney function in a community-based population.Lifetime risk of diabetes among First Nations and non-First Nations people.Association between First Nations ethnicity and progression to kidney failure by presence and severity of albuminuriaIntensive glycemic control and renal outcome.Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis.Determining research priorities through partnership with patients: an overview.Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease?A scoping review of adult chronic kidney disease clinical pathways for primary care.Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.Magnitude of rate of change in kidney function and future risk of cardiovascular events.Atrial fibrillation and chronic kidney disease: struggling through thick and thin.Chronic disease management interventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis.Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus.Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study.Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study.Strategies for BP Control in Developing Countries and Effects on Kidney Function.Automated estimated GFR reporting and late referral: are we expecting automatic benefits?Outcomes of extended-hours hemodialysis performed predominantly at home.Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.In Reply to 'International Normalized Ratio Control in Patients With Atrial Fibrillation and CKD'.
P50
Q26863404-C0BB5340-5D2B-4AB6-B7A9-26EF1F045A98Q27008473-2430CCE2-2603-4E3E-A773-02DE6CFF3598Q27307648-B3F04591-58E0-4CE6-9E2D-0B7AC58E883BQ33556332-326AE76E-288F-47BA-831F-645151CB8674Q33576435-CDAA4642-D6BB-47BB-9AFD-D935F583E1D2Q34308961-57D86D9D-C7A0-4352-B69B-6B52BEDB4E37Q34329966-49ED690D-8F53-4714-A8A2-DA7F8D3584B8Q34782523-F4A5FA08-C898-45FE-A5A3-BD17008A0E2EQ35070624-61D9FDA2-429E-46D5-94E9-444C4620989CQ35147789-44443112-7B5F-423E-871E-92C9BAB835B8Q35732973-7403FE19-2A18-445E-893B-5E047C2CCE99Q36073131-E3B5CBEF-B2FC-47CC-B6A3-F1C9F0312394Q36100273-5B32CC5D-DB22-482D-9BD7-E65D7C9A6A92Q36111877-758D4A08-0905-4813-BBE5-96D7E62985E8Q36398892-F45096CF-C1B7-464C-89AE-CA93F0FCC33CQ36443751-312A2B12-B711-4458-B391-98F0E67664C6Q36965146-0AB7F758-58FB-4170-B8EC-65C0DDE63E36Q37202754-E67943BA-17A5-45CC-9DC3-33485D94098EQ37382052-7B0CAD7F-F5A3-49ED-9B6D-E93A0A9BCF34Q37521514-D88B71AD-47B9-43D4-AAC5-314C0ED4DEEBQ37887396-3A35D7D4-720C-4D43-A7BB-85799335BC0FQ38105764-00E83D39-4792-4558-8658-7907EB11C30EQ38273837-D80FE9BB-4E59-420E-AA01-339D8440E70DQ38742173-5507DC74-D647-4EB3-B951-F9ADEC778DDBQ38783832-EC47B7A6-935B-401D-9C60-C4D7B79E5A35Q38852459-11F4D91F-424C-4C12-B679-103F9357DD0EQ38941637-513C92DB-FD8B-4C52-B9F1-6A1204B1C67BQ38954771-3124086E-7BA5-4556-821D-46259AF9F28DQ38981275-E3CF3094-5B46-4645-AC95-CD462B49F162Q39016039-87A924B0-FF93-4F33-B7BC-A95C767EB2D1Q39081705-818A808D-ED17-481F-8824-E5C9FE00020EQ39504175-49F02DBB-B558-4BF0-A52D-FE3B0C96FE24Q40132501-09FA2614-9C9F-4F51-AA21-C5A96E5D05B6Q41486453-5F35DC16-59F6-4F57-A89B-D7BE5DB2342CQ42697506-44155FD9-9F2B-47CB-A4AE-E4D3BF36C79FQ42743353-9454F5E5-7C21-43EC-BAF2-BA69692F939EQ44077557-86D5600E-12C1-407A-8896-4D33BF13210CQ44274037-9D383CB7-21F3-4C67-89FC-969B3F20677BQ47678855-8EB1DB55-7B69-44C7-B38C-4AD9799D659AQ48662210-F841161B-375D-4993-A311-DBD92F0CE59E
P50
description
researcher ORCID ID = 0000-0003-1460-7535
@en
wetenschapper
@nl
name
Min Jun
@ast
Min Jun
@en
Min Jun
@es
Min Jun
@nl
type
label
Min Jun
@ast
Min Jun
@en
Min Jun
@es
Min Jun
@nl
prefLabel
Min Jun
@ast
Min Jun
@en
Min Jun
@es
Min Jun
@nl
P106
P31
P496
0000-0003-1460-7535